WeVote

Bill

Bill

HB 205

Board of Homeland Security; development of a list of approved unmanned aircraft systems; provide

2025-2026 Regular Session Introduced by David Clark and 5 co-sponsors

HB 205 improves workers' compensation by regulating nonprescription drugs and setting payment limits, ensuring injured workers access necessary medications while lowering costs for employers.

Senate Read and Referred
0
WeVote Research Nonpartisan
Bill Summary · HB 205

Summary of HB 205: Relating to Workers' Compensation

Bill Overview

Bill Number: HB 205
Title: Relating to Workers' Compensation
Introduced On: January 15, 2025
Current Status: Deferred by the Committee on Consumer Protection & Commerce (CPC)
Classification: Bill
Subject Areas: Nonprescription Drugs, Payment Limitation, Workers' Compensation

Purpose and Intent

The primary purpose of HB 205 is to amend existing workers' compensation laws, specifically focusing on the regulation of nonprescription drugs and establishing payment limitations for these medications within the workers' compensation system. The bill aims to ensure that injured workers have access to necessary medications while also controlling costs associated with these drugs in the context of workers' compensation claims.

Key Provisions

  • Regulation of Nonprescription Drugs: The bill proposes to define and regulate the use of nonprescription drugs within the workers' compensation framework, ensuring that injured workers can obtain necessary medications without undue barriers.

  • Payment Limitations: HB 205 seeks to establish specific payment limits for nonprescription drugs covered under workers' compensation, which may help to manage overall costs for employers and insurance providers while still providing essential support to injured workers.

Impact

  • Injured Workers: The bill is designed to benefit injured workers by facilitating access to nonprescription medications that may be necessary for their recovery and rehabilitation.

  • Employers and Insurance Providers: By implementing payment limitations, the bill aims to reduce the financial burden on employers and insurance companies, potentially leading to lower workers' compensation premiums.

Legislative Timeline

  • January 15, 2025: Bill introduced and passed the First Reading.
  • January 21, 2025: Referred to the Labor & Employment (LAB), Consumer Protection & Commerce (CPC), and Finance (FIN) committees.
  • January 24, 2025: Scheduled for a hearing by the LAB committee.
  • January 28, 2025: LAB committee recommended the bill be passed with amendments.
  • January 30, 2025: Passed Second Reading as amended and referred to CPC.
  • February 4, 2025: Scheduled for a hearing by the CPC committee.
  • February 6, 2025: CPC committee recommended that the measure be deferred.

Conclusion

HB 205 represents a significant effort to reform aspects of workers' compensation related to nonprescription drugs. While the bill has undergone several legislative actions, its current status is deferred, indicating that further discussion and consideration are needed before any potential implementation. The bill's provisions, if enacted, could have a notable impact on the accessibility of medications for injured workers and the financial dynamics of the workers' compensation system.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.